Under-eye dark circles are among the most common aesthetic concerns brought to our clinic in Greater Kailash Part-1 — and among the most frequently treated incorrectly. The fundamental problem is that “dark circles” is not a single condition. It is a clinical category that encompasses at least four distinct causes, each with a different underlying mechanism and a correspondingly different treatment. Patients who have applied eye cream for years without meaningful improvement, or had a treatment that helped temporarily but did not last, are almost always dealing with a cause-treatment mismatch — not a failure of the treatments themselves.
Getting dark circles treatment south delhi right requires identifying which type of dark circle is present — or which combination, since many patients have more than one contributing factor — and then selecting the treatment that addresses the specific mechanism. This guide explains the four causes of periorbital darkness, what distinguishes them clinically, and what each one responds to.
Key Takeaways
- Dark Circles Have Four Distinct Causes: Vascular, pigmentary, structural (hollow), and lymphatic — each requires a different treatment. Eye cream addresses none of them definitively.
- Tear Trough Fillers Address Hollowing, Not Pigment: HA fillers in the tear trough correct volumetric deficit and shadow — they do not lighten intrinsic pigmentation.
- QS NdYAG Laser Treats Pigmentary Dark Circles: QS NdYAG periorbital laser toning addresses periorbital melanosis — but is ineffective for vascular or structural dark circles.
- PDRN and PRP Support Tissue Quality: PDRN and PRP improve the quality of periorbital skin and tissue — useful as adjuncts in most types.
- Technique Matters Enormously in This Area: The periorbital region has the highest risk of filler complications in the face — cannula technique and vascular anatomy knowledge are non-negotiable requirements.
The Four Causes of Under-Eye Dark Circles — and How to Tell Them Apart
1. Vascular Dark Circles
Vascular dark circles appear as a blue, purple, or pink-blue discolouration under the eye. They are caused by the visibility of the underlying periorbital vasculature — the fine veins and capillaries beneath the thin, translucent periorbital skin — through the skin surface. The periorbital skin is the thinnest skin on the face, and in patients with naturally thin skin, visible subcutaneous fat loss with age, or lymphatic congestion under eye, these vessels show through more prominently.
The clinical test is simple: press gently on the dark area with a finger. If the colour blanches (lightens significantly) under pressure, it is predominantly vascular. Vascular dark circles do not respond to topical pigmentation treatments or laser toning — the pigment is not in the skin, it is the colour of blood vessels beneath it. Treatments that improve the skin thickness and quality above the vessels — PDRN, PRP under eye — and those that increase the subcutaneous volume between the skin and the vessel (filler in appropriate cases) produce the most meaningful improvement.
2. Pigmentary Dark Circles (Periorbital Melanosis)
Periorbital melanosis is true pigmentation of the periorbital skin — excess melanin in the epidermis or superficial dermis of the lower eyelid and orbital rim. It presents as a brown discolouration that does not change with pressure and is most prominent in the inner corner of the eye. It is significantly more common in patients with Fitzpatrick type IV–VI Indian skin — the same genetic melanocyte reactivity that makes Indian skin prone to post-inflammatory hyperpigmentation also predisposes to constitutional periorbital pigmentation.
Contributing factors include sun exposure (UV directly stimulates melanocytes in the periorbital skin), rubbing (the friction of eye rubbing from allergies or habit triggers post-inflammatory pigment production), and genetic predisposition — many South Delhi patients report the condition in parents and grandparents. QS NdYAG periorbital laser toning, applied in low-fluence toning mode to the periorbital area, selectively fragments melanin deposits — producing progressive lightening over a series of sessions. Sun protection and topical tyrosinase inhibitors (vitamin C, kojic acid, arbutin) are essential adjuncts to maintain results and prevent re-pigmentation from ongoing UV exposure.
3. Structural Dark Circles — Tear Trough Deformity and Hollowing
Tear trough deformity is not a pigmentation problem — it is a structural one. The tear trough is the groove that runs from the inner corner of the eye along the lower orbital rim. In youth, subcutaneous fat in this area provides a smooth transition between the lower eyelid and the cheek. With ageing — or in patients who are constitutionally predisposed to early fat pad deflation in this area — this fat diminishes, the groove deepens, and a shadow forms in the hollow. This shadow is what creates the appearance of dark circles, even when the skin itself has no excess pigmentation.
The clinical test: look in a mirror and tilt your head slightly back, reducing the overhead lighting on the under-eye area. If the “darkness” reduces significantly when the shadow is removed by the changed lighting angle, the cause is predominantly structural — shadow from hollowing, not intrinsic pigment. The appropriate treatment is volumetric replacement: hyaluronic acid tear trough filler placed in the deep periosteal plane along the orbital rim, which lifts the hollow and eliminates the shadow. This is one of the highest-impact procedures in facial aesthetics — but one of the highest-risk for complications if performed without thorough vascular anatomy knowledge and appropriate technique.
4. Lymphatic Congestion and Puffiness
Lymphatic congestion under eye presents as puffiness or swelling under the eyes — most prominent in the morning and improving through the day as fluid drains with gravity and movement. It is caused by sluggish periorbital lymphatic drainage, often worsened by salt intake, alcohol, poor sleep, allergies, and air conditioning. Allergic shiners — a specific presentation of dark circles from chronic allergic rhinitis — are driven by venous congestion from nasal inflammatory engorgement and represent a combined vascular and lymphatic mechanism.
Lymphatic congestion does not respond to filler, laser, or pigmentation treatment — the intervention is management of the underlying driver (allergy treatment, sleep hygiene, dietary modification) combined with techniques to improve lymphatic flow. Cold compresses, lymphatic drainage massage, and addressing allergy with appropriate antihistamine treatment (if rhinitis is present) are the relevant approaches.
Tear Trough Filler: The Most Important Treatment to Get Right
The tear trough is one of the most technically demanding areas for filler injection in the face. The periorbital anatomy includes the infraorbital artery and its branches — inadvertent intravascular injection in this area carries risk of vascular occlusion and, in rare cases, visual compromise. The skin overlying the tear trough is extremely thin — product placed too superficially produces the Tyndall effect (a blue-grey discolouration from superficial HA visible through thin skin), which is one of the most common and visible filler complications in this area.
The correct technique — placing a soft, low-G-prime HA filler in the deep periosteal plane along the orbital rim using a blunt-tipped cannula rather than a needle — minimises both the Tyndall risk and the vascular risk. The cannula approach reduces the probability of inadvertent vessel penetration, and the deep plane placement keeps the product well away from the superficial skin where Tyndall effect occurs. Appropriate patient selection — patients with a definite hollow and good skin quality — and conservative volume placement are equally important.
All filler procedures at our Greater Kailash Part-1 clinic, including tear trough treatment, are performed personally by Dr. Rajat Kandhari using cannula technique. Results are visible immediately and typically last twelve to eighteen months.
Combining Treatments: Why Most Patients Need More Than One Approach
Many patients presenting with under eye hollow treatment delhi concerns have more than one contributing factor — a combination of structural hollowing, periorbital melanosis, and vascular visibility. A treatment plan that addresses only one produces partial improvement. A coordinated plan — tear trough filler for the structural component, QS NdYAG periorbital laser toning for the pigmentary component, and PDRN injections to improve periorbital skin quality and reduce the inflammatory micro-environment that drives both pigmentation and vascular visibility — produces comprehensive and lasting improvement.
| Dark Circle Type | Primary Treatment | Adjunct Treatment |
|---|---|---|
| Vascular | PDRN / PRP under eye | HA filler if hollow present |
| Pigmentary | QS NdYAG periorbital toning | Topical vitamin C, kojic acid, SPF |
| Structural (Hollow) | Tear trough HA filler — deep plane, cannula | Profhilo for skin quality |
| Lymphatic / Puffiness | Allergy management, lifestyle modification | Lymphatic drainage, cold compresses |
“Eye cream treats none of these causes meaningfully — it provides temporary hydration that reduces the translucency of the skin slightly. The actual drivers — pigment, volume loss, vascular visibility — require clinical treatment.” — Dr. Rajat Kandhari
For an under-eye assessment and personalised treatment plan, book a consultation at Dr. Rajat Kandhari’s clinic — S-79, Greater Kailash Part-1, South Delhi. Open Monday to Saturday, 9am to 8pm. Call or WhatsApp: +91 9315479193.
Frequently Asked Questions
Q1. What is the best treatment for dark circles on Indian skin?
It depends on the cause. For periorbital melanosis (true pigmentation), QS NdYAG periorbital laser toning combined with topical tyrosinase inhibitors and strict sun protection produces the best results. For tear trough deformity (hollowing and shadow), deep-plane HA filler placed via cannula is the most effective treatment. Most patients with Fitzpatrick IV–VI Indian skin have a combination of both — requiring a coordinated treatment plan.
Q2. Is tear trough filler safe?
Tear trough filler is safe when performed correctly — by a clinician with thorough knowledge of periorbital vascular anatomy, using appropriate product selection (soft, low-G-prime HA), correct technique (deep periosteal plane, cannula), and conservative volume. The primary risks — Tyndall effect from superficial placement and vascular compromise from incorrect technique — are both directly related to the technical approach, not the treatment itself. The procedure is reversible with hyaluronidase if results are unsatisfactory.
Q3. How many sessions of QS NdYAG laser are needed for periorbital pigmentation?
Typically six to eight sessions at two-week intervals for meaningful lightening of periorbital melanosis. Results are cumulative — progressive lightening with each session. Sun protection between sessions is essential to prevent UV re-stimulation of the melanocytes being treated. Maintenance sessions every three to four months are often recommended to prevent re-pigmentation.
Q4. Do dark circles come back after tear trough filler?
The filler itself lasts twelve to eighteen months before gradual degradation. The structural improvement — filling of the tear trough deformity — returns to the pre-treatment appearance as the filler is metabolised, unless retreated. The underlying ageing process (progressive fat pad deflation) continues — meaning the hollow may become more pronounced over time without maintenance. Many patients choose to repeat treatment annually or biannually to maintain the result.
Q5. Why do I have dark circles even after a full night’s sleep?
Dark circles that persist after adequate sleep and without significant puffiness are almost always structural or pigmentary — not primarily caused by tiredness. Sleep deprivation worsens the appearance of existing dark circles by increasing vascular congestion and reducing skin brightness, but it is not the primary cause in patients with consistent periorbital darkness regardless of sleep. A clinical assessment identifies whether the primary driver is periorbital melanosis, tear trough deformity, or vascular visibility.
Q6. Can PDRN help with dark circles?
Yes, as an adjunct treatment. PDRN injected in the periorbital area improves skin quality and thickness — reducing the translucency that allows vascular visibility — and its anti-inflammatory A2A receptor mechanism reduces the chronic inflammatory stimulus that drives periorbital melanosis. It is most effective when combined with the primary treatment for the specific dark circle type (laser for pigment, filler for hollow).
Q7. Where is the clinic located?
S-79, Greater Kailash Part-1, New Delhi 110048. Accessible from Hauz Khas, Defence Colony, Green Park, Lajpat Nagar, Malviya Nagar, and Saket. Open Monday to Saturday, 9am to 8pm. +91 9315479193.